Cargando…

Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors

Background: Combination therapy with the administration of GW5074 and sorafenib significantly induced necrotic death in various cancer cells in vivo, as well as prolonging the survival of an animal disease model due to significant suppression of the primary and metastatic lesions. We sought to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kao, Chien-Chang, Ho, Ching-Liang, Yang, Ming-Hsin, Tsai, Yi-Ta, Liu, Shu-Yu, Chang, Ping-Ying, Wu, Yi-Ying, Chen, Jia-Hong, Huang, Tzu-Chuan, Yehn, Ren-Hua, Dai, Ming-Shen, Chen, Yeu-Chin, Sun, Guang-Huan, Cha, Tai-Lung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031611/ https://www.ncbi.nlm.nih.gov/pubmed/35456276 http://dx.doi.org/10.3390/jcm11082183

Ejemplares similares

The Synergistic Cytotoxic Effects of GW5074 and Sorafenib by Impacting Mitochondrial Functions in Human Colorectal Cancer Cell Lines
por: Hu, Je-Ming, et al.
Publicado: (2022)

The Raf-1 inhibitor GW5074 and dexamethasone suppress sidestream smoke-induced airway hyperresponsiveness in mice
por: Lei, Ying, et al.
Publicado: (2008)

GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease
por: Connor, Sarah M., et al.
Publicado: (2022)

The Oxindole GW-5074 Inhibits JC Polyomavirus Infection and Spread by Antagonizing the MAPK-ERK Signaling Pathway
por: Kaiserman, Jacob, et al.
Publicado: (2023)

Conservation of Importin α Function in Apicomplexans: Ivermectin and GW5074 Target Plasmodium falciparum Importin α and Inhibit Parasite Growth in Culture
por: Walunj, Sujata B., et al.
Publicado: (2022)

Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo
por: Wang, Ping, et al.
Publicado: (2023)

Identification of a Splice Variant (c.5074+3A>C) of BRCA1 by RNA Sequencing and TOPO Cloning
por: Hong, Jinyoung, et al.
Publicado: (2021)

Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study
por: Peng, Tzu-Rong, et al.
Publicado: (2021)

HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
por: Suk, Fat-Moon, et al.
Publicado: (2022)

Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
por: Kao, Chien‐Chang, et al.
Publicado: (2021)

GW Stewart
por: Kilmer, Misha E, et al.
Publicado: (2010)

Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib
por: Hsieh, Ming-Han, et al.
Publicado: (2020)

Effects of robot-assisted versus hand-assisted nephroureterectomy on circulating tumor cells for upper urinary tract urothelial carcinoma
por: Ting, Hui-Kung, et al.
Publicado: (2021)

Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study
por: Jhuo, Yu-Cing, et al.
Publicado: (2023)

Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
por: Lee, I-Cheng, et al.
Publicado: (2022)

Programming in GW-BASIC
por: McBride, P K
Publicado: (1991)

A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome
por: Chen, Chin-Li, et al.
Publicado: (2021)

Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma
por: Huang, Kuo-Wei, et al.
Publicado: (2022)

Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma
por: Chiang, Pei-Jhang, et al.
Publicado: (2021)

Coalescence of Kerr Black Holes—Binary Systems from GW150914 to GW170814
por: Gwak, Bogeun
Publicado: (2019)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Workshop on GW Data Analysis
Publicado: (1997)

Instant MinGW starter
por: Shpigor, Ilya
Publicado: (2013)

Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats
por: Wang, Jie-ping, et al.
Publicado: (2022)

Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice
por: Sivilia, Sandra, et al.
Publicado: (2013)

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
por: Worden, Francis, et al.
Publicado: (2015)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma
por: Lai, Xiang-Me, et al.
Publicado: (2017)

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
por: Lee, I-Cheng, et al.
Publicado: (2022)

Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2019)

Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices
por: Chen, Yu-Guang, et al.
Publicado: (2015)

Sorafenib in patients with progressed and refractory bone tumors
por: Raciborska, Anna, et al.
Publicado: (2018)

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
por: Chiu, Chien-Ming, et al.
Publicado: (2018)

The GW/WG repeats of Drosophila GW182 function as effector motifs for miRNA-mediated repression
por: Chekulaeva, Marina, et al.
Publicado: (2010)

Mammalian GW220/TNGW1 is essential for the formation of GW/P bodies containing miRISC
por: Castilla-Llorente, Virginia, et al.
Publicado: (2012)

Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma
por: Suk, Fat-Moon, et al.
Publicado: (2021)

Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
por: Cheng, Tsung-Yi, et al.
Publicado: (2020)

The Roles of Glutamate Receptors and Their Antagonists in Status Epilepticus, Refractory Status Epilepticus, and Super-Refractory Status Epilepticus
por: Huang, Tzu-Hsin, et al.
Publicado: (2023)

GW-BASIC a su alcance
por: Albrecht, Bob, 1930-
Publicado: (1990)

What is the source of the PTA GW signal?
por: Ellis, John, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_itf04ilojvnqt5p7psl3vtds1f